“Advocate to bring intellectual property (IP) protection policy to levels that commensurate with Europe within the Canada-European Union Comprehensive Economic and Trade Agreement. Help to improve administration of scientific research and experimental development (SR&ED) tax credits, so that credits are received in time to offset costs of clinical trials.  Ensure that global head offices are aware of these improvements once they are made”.